The upcoming IPOs of Hinge Health and Omada Health are more than capital events—they may mark a turning point for HealthTech M&A. According to Nelson Advisors, these high-profile debuts are poised to reset investor sentiment, validate virtual care models, and push up acquisition multiples for digital health companies.
If the market rewards these IPOs, expect a ripple effect: rising benchmarks, faster deal activity, and renewed urgency among buyers who don’t want to miss the next breakout.